萘普生栓治疗产后宫缩痛临床观察

目的了解萘普生栓(NaproxenSuppositories)治疗产后宫缩痛的效果。方法对285例产后宫缩痛的产妇随机分成两组,实验组用萘普生一枚(0﹒25g)塞入肛门内2cm。对照组口服去痛片2片,记录疼痛开始减轻时间,镇痛效果、镇痛持续时间。结果①用药后15分钟疼痛开始减轻者:实验组80例,占55.17﹪;对照组0例。②疼痛缓解者:实验组108例,占74.5﹪。对照组60例,占42.8﹪。③镇痛时间超过8小时者:实验组110例,占79.1﹪。对照组20例,占16.7﹪。结论萘普生栓治疗产后宫缩痛高效、快速、持久。     

手术治疗中晚期胃癌126例报告

目的研究分析胃癌围手术期处理及并发症预防。方法本组126例,男84例,女42例,年龄34岁￣79岁,平均64岁,术前行特殊准备,纠正贫血、低蛋白血症,进行CRIS分级及FEV1测定。选择时机行胃空肠Roux-en-Y吻合手术治疗。结果临床治愈123人,死亡3人,并发症:切口感染8例,切口裂开6例,心肌梗死1例,十二指肠残端瘘1例,吻合口瘘2例,肺炎1例,并发症发生率15.0(%19/126)。结论①术前充分纠正贫血、低蛋白血症、水电解质紊乱,对心肺疾病者行CRIS分级评定和FEV1测定是保证手术成功的要点。②手术原则上行根治性切除,减少瘤负荷,以Roux-en-Y术式为佳。③术后输入端充分减压,输出端适时肠内营养,并严格心肺功能监测,合理应用抗生素,可望降低死亡率。     

Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine

The nucleocapsid （N） protein of SARS-coronavirus （SARS-CoV） is the key protein for the formation of the helical nucleocapsid during virion assembly. This protein is believed to be more conserved than other proteins of the virus, such as spike and membrane glycoprotein. In this study, the N protein of SARS-CoV was expressed in Escherichia coli DHSalpha and identified with pooled sera from patients in the convalescence phase of SARS. A plasmid pCI-N, encoding the full-length N gene of SARS-CoV, was constructed. Expression of the N protein was observed in COS1 cells following transfection with pCI-N. The immune responses induced by intramuscular immunization with pCI-N were evaluated in a murine model. Serum anti-N immunoglobutins and splenocytes proliferative responses against N protein were observed in immunized BALB/c mice. The major immunoglobulin G subclass recognizing N protein was immunoglobulin G2a, and stimulated splenocytes secreted high levels of gamma interferon and IL-2 in response to N protein. More importantly, the immunized mice produced strong delayed-type hypersensitivity （DTH） and CD^8＋ CTL responses to N protein.     

浅析医疗机构中志愿者体系的管理和发展

医疗志愿者体系发展至今，在国外已有相当的规模和管理机制，但是对于国内的医疗机构来说，仍在不断的探索中。本文将结合复旦大学附属儿科医院于2002年6月1日成立的首批“阳光爱心”志愿者队伍的情况，探究志愿者体系在医疗机构中的管理和发展。     

Sedation with sufentanil and midazolam decreases pain in patients undergoing upper limb surgery under multiple nerve block

Multiple nerve blocks may be painful and a source of discomfort. We assessed the efficacy of sufentanil 5 microg combined with midazolam 1 mg in decreasing pain in outpatients after a midhumeral multiple nerve stimulation technique. Visual analog scores for pain were significantly lower in those patients who received sedation before the block, both at the time of block performance (14 +/- 1 vs 27 +/- 2 mm, P < 0.0001) and at discharge (11 +/- 1 vs 24 +/- 2 mm, P < 0. 0001). We conclude that the association of sufentanil and midazolam produced minimal sedation while significantly reducing pain experienced by patients undergoing multiple nerve stimulation.     

中医疾病证候学研究方法初探

此次调查在西医辨病的基础上,以中医辨证理论方法为核心,按照事先设计的方案,收集特定时间内膝关节骨关节炎患者的病状,先进行计量诊断确立辨证要素,再进行聚类分析及logistic回归分析等筛选出特异性较高的症状,为疾病辨证分型、辨证标准的阐明提供依据.是一种值得介绍的中医证候研究方法.     

弦滑脉辨析--与傅文胜、薄震东、孙建中商榷

《中医杂志》1991年第2期薄震东、孙建中的《“弦滑”脉之管见》(以下简称《管见》)，与2000年第9期傅文胜的《脉弦滑质疑》(以下简称《质疑》)，从不同角度论述了相同的观点：弦、滑脉不能相兼。细阅两文，笔者发现两文中颇多错讹之处。两文作者对弦、滑两种脉象都尚未了解清楚。王叔和说脉诊是“在心易了，指下难明。”倘若在心还尚未“了”，指下又岂能“明”?为免贻误后学，不能不就弦、滑脉象作进一步辨析。     

小脑参与认知功能机制的研究进展

认知是指人脑为获取和应用知识,将外界信息转化成内在心理活动的复杂过程。自 1998年Schmahmann和Sherman提出“小脑认知-情感综合征”起,小脑认知功能的研究越来越受到关注。 本文通过回顾国内外相关研究,从小脑的解剖与认知功能、小脑的神经网络机制以及交叉性小脑神经 机能联系不能 3 个角度探讨了小脑在认知神经网络中的作用及机制,旨在提高对小脑参与认知功能的 认识。     

腓骨髓内钉与切开复位钉板系统治疗腓骨远端骨折的疗效分析

目的 比较腓骨髓内钉与切开复位钉板系统治疗腓骨远端骨折的疗效.方法 回顾性分析2017年10月至2019年10月于锦州医科大学附属第一医院采用手术治疗腓骨骨折的患者,按照纳入、排除标准筛选病例,最终A组髓内钉组25例纳入研究、B组钉板内固定组35例纳入研究.比较两组入院至行腓骨手术的时间,手术时长,腓骨术口总长度,AO...     

Identification of Inhibitors and Drug Targets for Human Adenovirus Infections

Adenoviruses can cause infections in people of all ages at all seasons of the year. Adenovirus infections cause mild to severe illnesses. Children, immunocompromised patients, or those with existing respiratory or cardiac disease are at higher risk. Unfortunately, there are no commercial drugs or vaccines available on the market for adenovirus infections. Therefore, there is an urgent need to discover new antiviral drugs or drug targets for adenovirus infections. To identify potential antiviral agents for adenovirus infections, we screened a drug library containing 2138 compounds, most of which are drugs with known targets and past phase I clinical trials. On a cell-based assay, we identified 131 hits that inhibit adenoviruses type 3 and 5. A secondary screen confirmed the antiviral effects of 59 inhibitors that inhibit the replication of adenoviruses type 3 or 5. Most of the inhibitors target heat shock protein, protein tyrosine kinase, the mTOR signaling pathway, and other host factors, suggesting that these host factors may be essential for replicating adenoviruses. Through this study, the newly identified adenovirus inhibitors may provide a start point for developing new antiviral drugs to treat adenovirus infections. Further validation of the identified drug targets can help the development of new therapeutics against adenovirus infections.